The All information on this website is intended for Australian audience only. It is not designed to replace the advice of your doctor. Please consult your doctor for further information.
AstraZeneca Pty Ltd, Alma Road, North Ryde NSW 2113, Australia. ABN 54 009 682 311.
emla® is a registered trademark of AstraZeneca Pty Ltd.
References: 1. emla® Approved Product Information, March 2010 2. Data on File at AstraZeneca Pty Ltd. 3. Hamilton JG. Fam Pract 1995 Aug; 4(2): 169-175
Always read the label before using emla®. Use only as directed. See leaflet for further information.
Indications for emla®: Topical anaesthesia of the skin prior to vaccination. Active Ingredients: lignocaine 2.5% and prilocaine 2.5%.
Site last updated on 10.10.2014